STATERA BIOPHARMA
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch STAB and buy or sell other stocks, ETFs, and their options commission-free!About STAB
Statera Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Its proprietary product toll-like receptor (TLR) agonists in the biopharmaceutical industry with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532 have applications in mitigation of radiation injury and neutropenia an anemia.
CEOMichael Kevin Handley, MBA
CEOMichael Kevin Handley, MBA
Employees16
Employees16
HeadquartersFort Collins, Colorado
HeadquartersFort Collins, Colorado
Founded2003
Founded2003
Employees16
Employees16
STAB Key Statistics
Market cap21.42K
Market cap21.42K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume41.04K
Average volume41.04K
High today$0.0003
High today$0.0003
Low today$0.0003
Low today$0.0003
Open price$0.0003
Open price$0.0003
Volume47.20K
Volume47.20K
52 Week high$0.0133
52 Week high$0.0133
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
STATERA BIOPHARMA(STAB) stock is priced at $0.00, giving the company a market capitalization of 21.42K.
During the trading session on 2026-01-04, STATERA BIOPHARMA(STAB) shares reached a daily high of $0.00 and a low of $0.00. At a current price of $0.00, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 47.2K, compared to an average daily volume of 41.04K.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
The stock's 52-week range extends from a low of $0.00 to a high of $0.01.
People also own
Based on the portfolios of people who own STAB. This list is generated using Robinhood data, and it’s not a recommendation.